Phase 1 trial evaluation of SYS6006's COVID-19 mRNA vaccine's immunogenicity and safety.

Published Date: 05 Jul 2023

More than 600 million confirmed cases and 6.5 million fatalities have been attributed to the COVID-19 pandemic, which was brought on by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). mRNA-based vaccines have become popular.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

2.

Glioblastoma treatment breakthrough shows promise

3.

A computer-aided diagnostic system for improved detection of breast cancer.

4.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

5.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot